WHO ICTRP trial
A phase II Clinical Study of CP-4055 in patients with metastatic melanoma not…
EUCTR2005-000690-22-SE · EU Clinical Trials Register · Not Recruiting
Key facts
| Trial ID | EUCTR2005-000690-22-SE |
|---|---|
| Public title | A phase II Clinical Study of CP-4055 in patients with metastatic melanoma not previous treated with chemotherapy - CP4055-201 |
| Scientific title | A phase II Clinical Study of CP-4055 in patients with metastatic melanoma not previous treated with chemotherapy - CP4055-201 |
| Primary sponsor | Clavis Pharma as |
| Registry | EU Clinical Trials Register |
| Recruitment status | Not Recruiting |
| Study type | Interventional clinical trial of medicinal product |
| Countries | Sweden |
| Conditions | A phase II clinical study of CP-4055 in patients with metastatic melanoma not previous treated with chemotherapy |
| Interventions | Product Name: CP-4055 for infusion Product Code: CP-4055 Pharmaceutical Form: Concentrate for solution for infusion |
| Registration date | Jun 20, 2005 |
| Target size | 42 |
| Secondary IDs | CP4055-201 |
| Registry page | clinicaltrialsregister.eu |
At a glance
- No Results available
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About WHO ICTRP trial registrations
The WHO ICTRP combines trial registrations from primary registries worldwide into a single searchable index. Contact and ethics-committee details are not shown here.
Source: World Health Organization (WHO), International Clinical Trials Registry Platform (ICTRP) · Source date: